This country profile provides an overview of Namibia’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
NR
Bilharzia
NR
River blindness
N/A

Priorities for progress in Namibia

  • Namibia should work to clarify the epidemiology of bilharzia and intestinal worms in the country, and work to build a preventive chemotherapy programme in line with WHO recommendations.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Namibia does not require mass treatment for elephantiasis.

Blinding trachoma

Namibia may require interventions for blinding trachoma, investigation needed.

Intestinal worms

Treatment coverage was 21% in 2016 and not reported in 2017.

Pre-sch and school-aged children needing treatment
0.81m
Pre-sch and school-aged children needing treatment
Not reported

Bilharzia

Treatment coverage was not reported in 2016 or 2017.

School-aged children needing treatment
0.21m
School-aged children needing treatment
Not reported

River blindness

Namibia does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Namibia.